Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 2171019-55-7, Afimetoran [usan], Lxp7mzl0vf, Bms-986256, Unii-lxp7mzl0vf, Afimetoran [inn]
Molecular Formula
C26H32N6O
Molecular Weight
444.6  g/mol
InChI Key
SNFVHLQYHFQOEP-UHFFFAOYSA-N
FDA UNII
LXP7MZL0VF

AFIMETORAN is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]acetamide
2.1.2 InChI
InChI=1S/C26H32N6O/c1-15(2)24-20-11-19(18-7-9-31(10-8-18)13-23(27)33)5-6-22(20)30-25(24)21-12-32-26(28-14-29-32)17(4)16(21)3/h5-6,11-12,14-15,18,30H,7-10,13H2,1-4H3,(H2,27,33)
2.1.3 InChI Key
SNFVHLQYHFQOEP-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
LXP7MZL0VF
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 2171019-55-7

2. Afimetoran [usan]

3. Lxp7mzl0vf

4. Bms-986256

5. Unii-lxp7mzl0vf

6. Afimetoran [inn]

7. Bms 986256

8. Afimetoran (usan)

9. 2-(4-(2-(7,8-dimethyl(1,2,4)triazolo(1,5-a)pyridin-6-yl)-3-(propan-2-yl)-1h-indol-5-yl)piperidin-1-yl)acetamide

10. 1-piperidineacetamide, 4-(2-(7,8-dimethyl(1,2,4)triazolo(1,5-a)pyridin-6-yl)-3-(1-methylethyl)-1h-indol-5-yl)-

11. Refchem:110007

12. 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1h-indol-5-yl)piperidin-1-yl)acetamide

13. Who 11516

14. 2-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1h-indol-5-yl]piperidin-1-yl]acetamide

15. 1-piperidineacetamide, 4-(2-(7,8-dimethyl(1,2,4)triazolo(1,5-a)pyridin-6-yl)-3- (1-methylethyl)-1h-indol-5-yl)-

16. Afimetoran [who-dd]

17. Orb1303504

18. Afimetoran (bms-986256)

19. Chembl4650329

20. Schembl19761011

21. C26h32n6o

22. Bdbm273241

23. Ex-a6745

24. Us10071079, Example 15

25. Mfcd34578322

26. Akos040757385

27. Da-70624

28. Ms-28017

29. Hy-139567

30. Cs-0213544

31. D11908

32. G18517

33. 2-(4-(2-(7,8-dimethyl(1,2,4)triazolo(1,5-a)pyridin-6-yl)-3-(propan-2-yl)-1h-indol- 5-yl)piperidin-1-yl)acetamide

34. 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1h-indol-5-yl) Piperidin-1-yl)acetamide

35. 2-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1h-indol-5-yl]-1-piperidyl]acetamide

2.4 Create Date
2018-01-29
3 Chemical and Physical Properties
Molecular Weight 444.6 g/mol
Molecular Formula C26H32N6O
XLogP33.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area92.3
Heavy Atom Count33
Formal Charge0
Complexity694
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 Mechanism of Action

Afimetoran acts as an antagonist of TLR 7/8.